Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latvia & Lithuania progress towards alignment:

This article was originally published in Clinica

Executive Summary

The texts of the trade agreements between Latvia and Lithuania and the European Union were published in the Official Journal of the European Communities on July 31. These trade agreements, known as Protocols to the European Agreements on European Conformity Assessment and Acceptance of Industrial Products (PECAs), do not yet cover medical devices. But both countries making good progress towards aligning their laws and systems with the EU and the current PECA texts provide a basis for the swift inclusion of medical devices once alignment occurs. The agreement between Latvia and the EU covers electrical safety, electromagnetic compatibility, toys and construction products, while that between Lithuania and the EU covers machinery, lifts, personal protective equipment, electrical safety, electromedical compatibility, and simple pressure vessels.

You may also be interested in...

P&G: Sales Growth Strongest When Rising Tide Floats All Competitors Across All Categories

P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.

COVID-19 Vaccine 'Brexit Bonus' A Myth

The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.

Warning Letter Close-Outs – November 2020

The US Food and Drug Administration posted two device-related closeout letters in November.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts